US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 62.360
  • +0.070+0.11%
Close Feb 14 16:00 ET
  • 62.360
  • 0.0000.00%
Post 17:01 ET
3.13BMarket Cap24.55P/E (TTM)

Haemonetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 28, 2024
(Q2)Sep 28, 2024
(Q1)Jun 29, 2024
(FY)Mar 30, 2024
(Q4)Mar 30, 2024
(Q3)Dec 30, 2023
(Q2)Sep 30, 2023
(Q1)Jul 1, 2023
(FY)Apr 1, 2023
(Q4)Apr 1, 2023
Total revenue
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
1.17B
304.42M
Operating revenue
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
--1.17B
--304.42M
Cost of revenue
-2.14%155M
7.04%158.07M
11.93%161.25M
11.55%617.51M
12.97%167.38M
8.04%158.38M
5.78%147.67M
20.87%144.07M
553.56M
148.17M
Gross profit
8.82%193.55M
9.93%187.44M
4.58%174.92M
12.43%691.55M
12.58%175.91M
12.07%177.87M
8.00%170.51M
17.57%167.27M
615.1M
156.25M
Operating expense
1.99%134.52M
0.39%135.74M
18.98%135.17M
12.80%518.25M
13.32%137.54M
14.26%131.89M
21.65%135.21M
1.89%113.61M
459.45M
121.38M
Selling and administrative expenses
-4.70%106.46M
-7.26%106.95M
15.79%108.25M
14.63%431.78M
13.81%111.26M
18.01%111.71M
25.31%115.32M
1.36%93.49M
--376.68M
--97.76M
Research and development costs
19.33%15.83M
30.52%16.53M
14.24%14.45M
8.59%54.44M
1.36%15.86M
4.54%13.27M
16.24%12.67M
16.02%12.65M
--50.13M
--15.64M
Depreciation amortization depletion
76.96%12.23M
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
-12.15%7.22M
-10.68%7.47M
--32.64M
--7.97M
-Depreciation and amortization
76.96%12.23M
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
-12.15%7.22M
-10.68%7.47M
--32.64M
--7.97M
Operating profit
28.39%59.03M
46.44%51.7M
-25.91%39.76M
11.34%173.3M
10.00%38.36M
6.24%45.98M
-24.46%35.3M
74.40%53.66M
155.65M
34.87M
Net non-operating interest income expense
-367.52%-9.11M
-183.00%-6.99M
436.25%6.96M
11.02%-13.02M
-148.35%-6.53M
-84.74%-1.95M
56.44%-2.47M
60.76%-2.07M
-14.63M
-2.63M
Non-operating interest income
----
----
--6.96M
----
----
----
----
----
----
----
Non-operating interest expense
367.52%9.11M
183.00%6.99M
----
-11.02%13.02M
148.35%6.53M
84.74%1.95M
-56.44%2.47M
-60.76%2.07M
--14.63M
--2.63M
Other net income (expense)
-2,303.93%-8.42M
382K
Special income (charges)
----
----
----
-2,303.93%-8.42M
----
----
----
----
--382K
--382K
-Less:Impairment of capital assets
----
----
----
--10.42M
----
----
----
----
--0
--0
-Gain on sale of business
----
----
----
423.56%2M
----
----
----
----
--382K
----
Income before tax
13.37%49.92M
36.16%44.7M
-9.45%46.71M
7.40%151.87M
-28.24%23.41M
4.27%44.03M
-20.04%32.83M
102.36%51.59M
141.4M
32.63M
Income tax
-2.85%12.42M
37.22%10.87M
-20.93%8.34M
31.94%34.31M
-6.04%3.05M
37.80%12.79M
0.79%7.92M
87.79%10.55M
26M
3.24M
Net income
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
115.4M
29.38M
Net income continuous Operations
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
--115.4M
--29.38M
Minority interest income
Net income attributable to the parent company
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
115.4M
29.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
115.4M
29.38M
Basic earnings per share
20.97%0.75
34.69%0.66
-7.41%0.75
2.20%2.32
-31.15%0.401
-4.62%0.62
-24.62%0.49
107.69%0.81
2.27
0.5825
Diluted earnings per share
21.31%0.74
37.50%0.66
-7.50%0.74
2.23%2.29
-29.82%0.4
-4.69%0.61
-25.00%0.48
110.53%0.8
2.24
0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Dec 28, 2024(Q2)Sep 28, 2024(Q1)Jun 29, 2024(FY)Mar 30, 2024(Q4)Mar 30, 2024(Q3)Dec 30, 2023(Q2)Sep 30, 2023(Q1)Jul 1, 2023(FY)Apr 1, 2023(Q4)Apr 1, 2023
Total revenue 3.66%348.54M8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M10.14%336.25M6.96%318.18M19.08%311.33M1.17B304.42M
Operating revenue 3.66%348.54M8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M10.14%336.25M6.96%318.18M19.08%311.33M--1.17B--304.42M
Cost of revenue -2.14%155M7.04%158.07M11.93%161.25M11.55%617.51M12.97%167.38M8.04%158.38M5.78%147.67M20.87%144.07M553.56M148.17M
Gross profit 8.82%193.55M9.93%187.44M4.58%174.92M12.43%691.55M12.58%175.91M12.07%177.87M8.00%170.51M17.57%167.27M615.1M156.25M
Operating expense 1.99%134.52M0.39%135.74M18.98%135.17M12.80%518.25M13.32%137.54M14.26%131.89M21.65%135.21M1.89%113.61M459.45M121.38M
Selling and administrative expenses -4.70%106.46M-7.26%106.95M15.79%108.25M14.63%431.78M13.81%111.26M18.01%111.71M25.31%115.32M1.36%93.49M--376.68M--97.76M
Research and development costs 19.33%15.83M30.52%16.53M14.24%14.45M8.59%54.44M1.36%15.86M4.54%13.27M16.24%12.67M16.02%12.65M--50.13M--15.64M
Depreciation amortization depletion 76.96%12.23M69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M-14.45%6.91M-12.15%7.22M-10.68%7.47M--32.64M--7.97M
-Depreciation and amortization 76.96%12.23M69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M-14.45%6.91M-12.15%7.22M-10.68%7.47M--32.64M--7.97M
Operating profit 28.39%59.03M46.44%51.7M-25.91%39.76M11.34%173.3M10.00%38.36M6.24%45.98M-24.46%35.3M74.40%53.66M155.65M34.87M
Net non-operating interest income expense -367.52%-9.11M-183.00%-6.99M436.25%6.96M11.02%-13.02M-148.35%-6.53M-84.74%-1.95M56.44%-2.47M60.76%-2.07M-14.63M-2.63M
Non-operating interest income ----------6.96M----------------------------
Non-operating interest expense 367.52%9.11M183.00%6.99M-----11.02%13.02M148.35%6.53M84.74%1.95M-56.44%2.47M-60.76%2.07M--14.63M--2.63M
Other net income (expense) -2,303.93%-8.42M382K
Special income (charges) -------------2,303.93%-8.42M------------------382K--382K
-Less:Impairment of capital assets --------------10.42M------------------0--0
-Gain on sale of business ------------423.56%2M------------------382K----
Income before tax 13.37%49.92M36.16%44.7M-9.45%46.71M7.40%151.87M-28.24%23.41M4.27%44.03M-20.04%32.83M102.36%51.59M141.4M32.63M
Income tax -2.85%12.42M37.22%10.87M-20.93%8.34M31.94%34.31M-6.04%3.05M37.80%12.79M0.79%7.92M87.79%10.55M26M3.24M
Net income 20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M115.4M29.38M
Net income continuous Operations 20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M--115.4M--29.38M
Minority interest income
Net income attributable to the parent company 20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M115.4M29.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M115.4M29.38M
Basic earnings per share 20.97%0.7534.69%0.66-7.41%0.752.20%2.32-31.15%0.401-4.62%0.62-24.62%0.49107.69%0.812.270.5825
Diluted earnings per share 21.31%0.7437.50%0.66-7.50%0.742.23%2.29-29.82%0.4-4.69%0.61-25.00%0.48110.53%0.82.240.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025